The immense potential of xenotransplantation in surgery

International Journal of Surgery

Volumn 9, Issue 2, 2011, Pages 122-129

  Cooper, David K C ^a   Ayares, D ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b REVIVICOR INC   (United States)

Author keywords

Cornea; Islets; Neuronal cells; Organs; Pig; Xenotransplantation

Indexed keywords

BLOOD CLOTTING; CELL TRANSPLANTATION; CORNEA TRANSPLANTATION; DIABETES MELLITUS; DISSEMINATED INTRAVASCULAR CLOTTING; DNA MODIFICATION; ERYTHROCYTE TRANSFUSION; GLYCEMIC CONTROL; HEART GRAFT; HUMAN; HUMORAL IMMUNITY; KIDNEY GRAFT; NONHUMAN; ORGAN INJURY; PANCREAS ISLET TRANSPLANTATION; PARKINSON DISEASE; PRIMATE; PRIORITY JOURNAL; REVIEW; SWINE; THROMBOCYTE ACTIVATION; THROMBOTIC THROMBOCYTOPENIC PURPURA; XENOTRANSPLANTATION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CELL TRANSPLANTATION; CORNEAL TRANSPLANTATION; ERYTHROCYTE TRANSFUSION; GENETIC ENGINEERING; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; NEURONS; ORGAN TRANSPLANTATION; PRIMATES; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 79952107552     PISSN: 17439191     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijsu.2010.11.002     Document Type: Review

References (92)

1. Cooper D.K.C., Lanza R.P. Xeno-The promise of transplanting animal organs into humans 2000, Oxford University Press, New York, 1-274.
2. Roux F.A., Sai P., Deschamps J.Y. Xenotransfusions, past and present. Xenotransplantation 2007, 14:208-216.
3. Hara H, Cooper DKC. Xenotransplantation - the future of corneal transplantation? Cornea. in press.
4. Taniguchi S., Cooper D.K.C. Clinical xenotransplantation - past, present and future. Ann R Coll Surg Engl 1997, 79:13-19.
5. Deschamps J.Y., Roux F.A., Sai P., Gouin E. History of xenotransplantation. Xenotransplantation 2005, 12:91-109.
6. Lexer G., Cooper D.K.C., Rose A.G., Wicomb W.N., Rees J., Keraan M., et al. Hyperacute rejection in a discordant (pig to baboon) cardiac xenograft model. J Heart Transplant 1986, 5:411-418.
7. Cooper D.K.C., Human P.A., Lexer G., Rose A.G., Rees J., Keraan M., et al. Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon. J Heart Transplant 1988, 7:238-246.
8. Ezzelarab M., Garcia B., Azimzadeh A., Sun H., Lin C.C., Hara H., et al. The innate immune response and activation of coagulation in α1,3-galactosyltransferase gene-knockout xenograft recipients. Transplantation 2009, 87:805-812.
9. Yamada K., Sachs D.H., DerSimonian H. Human anti-porcine xenogeneic T cell response. Evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition. J Immunol 1995, 1(155):5249-5256.
10. Lin Y.J., Hara H., Tai H.C., Long C., Tokita D., Yeh P., et al. Suppressive efficacy and proliferative capacity of human regulatory T cells in allogeneic and xenogeneic responses. Transplantation 2008, 86:1452-1462.
11. Rood P.P.M., Tai H.C., Hara H., Long C., Ezzelarab M., Lin Y.J., et al. Late onset of development of natural anti-nonGal antibodies in infant humans and baboons: implications for xenotransplantation in infants. Transplant Int 2007, 20:1050-1058.
12. Galili U., Shohet S.B., Kobrin E., Stults C.L., Macher B.A. Man, apes, and old world monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. J Biol Chem 1988, 263:17755-17762.
13. Good A.H., Cooper D.K.C., Malcolm A.J., Ippolito R.M., Koren E., Neethling F.A., et al. Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in man. Transplant Proc 1992, 24:559-562.
14. Cooper D.K.C. Depletion of natural antibodies in non-human primates - a step towards successful discordant xenografting in man. Clin Transplantation 1992, 6:178-183.
15. Cooper D.K.C., Good A.H., Koren E., Oriol R., Malcolm A.J., Ippolito R.M., et al. Identification of α-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. Transpl Immunol 1993, 1:198-205.
16. Oriol R., Ye Y., Koren E., Cooper D.K.C. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation 1993, 56:1433-1442.
17. Rose A.G., Cooper D.K.C., Human P.A., Reichenspurner H., Reichart B. Histopathology of hyperacute rejection of the heart - experimental and clinical observation in allografts and xenografts. J Heart Transplant 1991, 10:223-234.
18. Rose A.G., Cooper D.K.C. A histopathologic grading system of hyperacute (humoral, antibody-mediated) cardiac xenograft and allograft rejection. J Heart Lung Transplant 1996, 15:804-817.
19. Rose A.G., Cooper D.K.C. Venular thrombosis is the key event in the pathogenesis of antibody-mediated cardiac rejection. Xenotransplantation 2000, 7:31-41.
20. Dalmasso A.P., Vercellotti G.M., Platt J.L., Bach F.H. Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor. Potential for prevention of xenograft hyperacute rejection. Transplantation 1991, 52:530-533.
21. White D.J., Oglesby T., Liszewski M.K., Tedja I., Hourcade D., Wang M.W., et al. Expression of human decay accelerating factor or membrane cofactor protein genes on mouse cells inhibits lysis by human complement. Transpl Int 1992, 5:648-650.
22. Cozzi E., White D.J.G. The generation of transgenic pigs as potential organ donors for humans. Nat Med 1995, 1:964-969.
23. Loveland B.E., Milland J., Kyriakou P., Thorley B.R., Christiansen D., Lanteri M.B., et al. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons. Xenotransplantation 2004, 11:171-183.
24. McGregor C.G., Davies W.R., Oi K., Teotia S.S., Schirmer J.M., Risdahl J.M., et al. Cardiac xenotransplantation:recent preclinical progress with 3-month median survival. J Thorac Cardiovasc Surg 2005, 130:844-851.
25. Byrne G.W., McCurry K.R., Martin M.J., McClellan S.M., Platt J.L., Logan J.S. Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation 1997, 63:149-155.
26. Cowan P.J., Aminian A., Barlow H., Brown A.A., Chen C.G., Fisicaro N., et al. Renal xenografts from triple-transgenic pigs are not hyperacutely rejected but cause coagulopathy in non-immunosuppressed baboons. Transplantation 2000, 69:2504-2515.
27. Hara H., Long C., Lin Y.J., Tai H.C., Ezzelarab M., Ayares D., et al. In vitro investigation of pig cells for resistance to human antibody-mediated rejection. Transplant Int 2008, 21:1163-1174.
28. Cooper D.K.C., Koren E., Oriol R. Genetically engineered pigs. Lancet 1993, 342:682-683.
29. Phelps C.J., Koike C., Vaught T.D., Boone J., Wells K.D., Chen S.H., et al. Production of α1,3-galactosyltransferase-deficient pigs. Science 2003, 299:411-414.
30. Kolber-Simonds D., Lai L., Watt S.R., Denaro M., Arn S., Augenstein M.L., et al. Production of α1,3-galactosyltransferase null pigs via nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc Natl Acad Sci USA 2004, 19:7335-7340.
31. Kuwaki K., Tseng Y.L., Dor F.J., Shimizu A., Houser S.L., Sanderson T.M., et al. Heart transplantation in baboons using α1,3-galactosyltransferase gene-knockout pigs as donors:initial experience. Nat Med 2005, 11:29-31.
32. Tseng Y.L., Kuwaki K., Dor F.J., Shimizu A., Houser S., Hisashi Y., et al. α 1,3-galactosyltransferase gene-knockout pig heart transplantation in baboons with survival approaching six months. Transplantation 2005, 80:1493-1500.
33. Yamada K., Yazawa K., Shimizu A., Iwanaga T., Hisashi Y., Nuhn M., et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of α1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med 2005, 11:32-34.
34. Hara H., Ezzelarab M., Rood P.P.M., Lin Y.J., Busch J., Ibrahim Z., et al. Allosensitized humans are at no greater risk of humoral rejection of GT-KO pig organs than other humans. Xenotransplantation 2006, 13:357-365.
35. Ezzelarab M., Hara H., Busch J., Rood P.P., Zhu X., Ibrahim Z., et al. Antibodies directed to pig nonGal antigens in naïve and sensitized baboons. Xenotransplantation 2006, 13:400-407.
36. Rood P.P.M., Hara H., Busch J.L., Ezzelarab M., Zhu X., Ball S., et al. Incidence and cytotoxicity of antibodies in cynomolgus monkeys directed to nonGal antigens, and their relevance for experimental models. Transpl Int 2006, 19:158-165.
37. Yeh P., Ezzelarab M., Bovin N., Hara H., Long C., Tomiyama K., et al. Investigation of potential carbohydrate antigen targets for human and baboon antibodies. Xenotransplantation 2010, 17:197-206.
38. Azimzadeh A.M., Kelishadi S., Ezzelarab M., Singh A.K., Stoddard T., Zhang T., et al. Early graft failure of GTKO pig organs in baboons is reduced by HCPRP expression. Am J Transplant 2010, 10(Suppl. 4):186. (Abstract 499).
39. Chen G., Qian H., Starzl T., Sun H., Garcia B., Wang X., et al. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat Med 2005, 11:1295-1298.
40. Phelps C., Ball S., Vaught T., Vance A.M., Mendicino M., Monahan J.A., et al. Production and characterization of transgenic pigs expressing porcine CTLA4-Ig. Xenotransplantation 2009, 16:477-485.
41. Hara H., Crossley T., Witt W., Long C., Fang J., Ezzelarab M., et al. Dominant-negative CIITA transgenic pigs - effect on the human anti-pig T cell immune response and immune status. Am J Transplant 2010, 10(Suppl. 4):187. Abstract 503.
42. Kuwaki K., Knosalla C., Dor F.J., Gollackner B., Tseng Y.L., Houser S., et al. Suppression of natural and elicited antibodies in pig-to-baboon heart transplantation using a human anti-CD154 monoclonal antibody-based regimen. Transplant 2004, 4:363-372.
43. Ierino F.L., Kozlowski T., Siegel J.B., Shimizu A., Colvin R.B., Banerjee P.T., et al. Disseminated intravascular coagulation in association with the delayed rejection of pig-to-baboon renal xenografts. Transplantation 1998, 66:1439-1450.
44. Kozlowski T., Shimizu A., Lambrigts D., Yamada K., Fuchimoto Y., Glaser R., et al. Porcine kidney and heart transplantation in baboons undergoing a tolerance induction regimen and antibody adsorption. Transplantation 1999, 67:18-30.
45. Bühler L., Basker M., Alwayn I.P., Goepfert C., Kitamura H., Kawai T., et al. Coagulation and thrombotic disorders associated with pig organ and hematopoietic cell transplantation in nonhuman primates. Transplantation 2000, 70:1323-1331.
46. Lin C.C., Ezzelarab M., Shapiro R., Ekser B., Long C., Hara H., et al. Tissue factor expression on recipient platelets is associated with consumptive coagulopathy in pig-to-primate kidney xenotransplantation. Am J Transplant 2010, 10:1556-1568.
47. Knosalla C., Yazawa K., Behdad A., Bodyak N., Shang H., Bühler L., et al. Renal and cardiac endothelial heterogeneity impact acute vascular rejection in pig-to-baboon xenotransplantation. Am J Transplant 2009, 9:1006-1016.
48. Bach F.H., RobsonSC Ferran C., Winkler H., Millan M.T., Stuhlmeier K.M., et al. Endothelial cell activation and thromboregulation during xenograft rejection. Immunol Rev 1994, 141:5-303.
49. Gollackner B., GohSK Qawi I., Buhler L., Knosalla C., Daniel S., et al. Acute vascular rejection of xenografts:roles of natural and elicited xenoreactive antibodies in activation of vascular endothelial cells and induction of procoagulant activity. Transplantation 2004, 77:1735-1741.
50. Robson S.C., Cooper D.K.C., d'Apice A.J.F. Disordered regulation of coagulation and platelet activation in xenotransplantation. Xenotransplantation 2000, 7:166-176.
51. Schulte am Esch J., Rogiers X., Robson S.C. Molecular incompatibilities in hemostasis between swine and men-impact on xenografting. Ann Transplant 2001, 6:12-16.
52. Cowan P.J. Coagulation and the xenograft endothelium. Xenotransplantation 2007, 14:7-12.
53. Pierson R.N., Dorling A., Ayares D., Rees M.A., Seebach J.D., Fishman J.A., et al. Current status of xenotransplantation and prospects for clinical application. Xenotransplantation 2009, 16:263-280.
54. Houser S.L., Kuwaki K., Knosalla C., Dor F.J., Gollackner B., Cheng J., et al. Thrombotic microangiopathy and graft arteriopathy in pig hearts following transplantation into baboons. Xenotransplantation 2004, 11:416-425.
55. Wong B.S., Yamada K., Koumi M., Weiner J., O'Malley P.E., Tseng Y.L., et al. Allosensitization does not increase the risk of xenoreactivity to Ά1,3-Galactosyltransferase gene-knockout (GalT-KO) miniature swine in patients on transplantation waiting lists. Transplantation 2006, 82:314-319.
56. Cooper D.K.C., Tseng Y.L., Saidman S.L. Allo- and xeno-antibody cross-reactivity in transplantation. Transplantation 2004, 77:1-5.
57. Mohiuddin M.M., Corcoran P.C., Singh A.K., Hoyt R.F., Thomas M.L., Eckhaus M.A., et al. Pig to baboon cardiac xenotransplantation:essential role of B cell depletion in prolonging cardiac xenograft survival. Am J Transplant 2010, 10(Suppl. 4):186. (Abstract 498).
58. McGregor C.G.A., Byrne G.W., Vlasin M., Walker R.C., Tazelaar H.D., Davies W.R., et al. Early cardiac function and gene expression after orthotopic cardiac xenotransplantation. Xenotransplantation 2009, 16:356. (Abstract IXA-O-2.4).
59. Cozzi E., Vial C., Ostlie D., Farah B., Chavez G., Smith K.G., et al. Maintenance triple immunosuppression with cyclosporin A, mycophenolate sodium and steroids allows prolonged survival of primate recipients of hDAF porcine renal xenografts. Xenotransplantation 2003, 10:300-310.
60. Griesemer A.D., Hirakata A., Shimizu A., Moran S., Tena A., Iwaki H., et al. Results of gal-knockout porcine thymokidney xenografts. Am J Transplant 2009, 9:2669-2678.
61. Ekser B., Long C., Echeverri G.J., Hara H., Ezzelarab M., Lin C.C., et al. Impact of thrombocytopenia on survival of baboons with genetically-modified pig liver transplants:clinical relevance. Am J Transplant 2010, 10:273-285.
62. Schroeder C., Allan J.S., Nguyen B.N., Wu G., Zhang T., Azimzadeh A.M., et al. Hyperacute rejection is attenuated in GalTKO swine lungs perfused ex vivo with human blood. Transplant Proc 2005, 37:512-513.
63. Nguyen B.H., Zwets E., Schroeder C., Pierson R.N., Azimzadeh A.M. Beyond antibody-mediated rejection: hyperacute lung rejection as a paradigm for dysregulated inflammation. Curr Drug Targets:Cardiovascular Hematological Disord 2005, 5:255-269.
64. Nguyen B.N., Azimzadeh A.M., Zhang T., Wu G., Schuurman H.J., Sachs D.H., et al. Life-supporting function of genetically modified swine lungs in baboons. J Thorac CV Surg 2007, 133:1354-1363.
65. Ibrahim Z., Busch J., Awwad M., Wagner R., Wells K., Cooper D.K.C. Selected physiologic compatibilities and incompatibilities between human and porcine organ systems. Xenotransplantation 2006, 13:488-499.
66. Ekser B., Echeverri G.J., Cortese-Hassett A., Yazer M.H., Long C., Meyer M., et al. Hepatic function after genetically-engineered pig liver transplantation baboons. Transplantation 2010, 90:483-493.
67. Hering B.J., Wijkstrom M., Graham M.L., Hårdstedt M., Aasheim T.C., Jie T., et al. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med 2006, 12:301-303.
68. Cardona K., Korbutt G.S., Milas Z., Lyon J., Cano J., Jiang W., et al. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med 2006, 12:304-306.
69. Dufrane D., Goebbels R.M., Saliez A., Gulot Y., Gianello P. Six-month survival of microencapsulated pig islets and alginate biocompatibility in primates:proof of concept. Transplantation 2006, 81:1345-1353.
70. van der Windt D.J., Bottino R., Casu A., Campanile N., Smetanka C., He J., et al. Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets. Am J Transplant 2009, 9:2716-2726.
71. Bennet W., Sundberg B., Lundgren T., Tibell A., Groth C.G., Richards A., et al. Damage to porcine islets of langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys:protective effects of sCR1 and heparin. Transplantation 2000, 69:711-719.
72. van der Windt D.J., Echeverri G., Cooper D.K.C. The choice of anatomical site for islet transplantation. Cell Transplant 2008, 17:1005-1014.
73. Rayat G.R., Rajotte R.V., Korbutt G.S. Potential application of neonatal porcine islets as treatment for type 1 diabetes:a review. Ann N Y Acad Sci 1999, 18:175-188.
74. Casu A., Bottino R., Balamurugan A.N., Hara H., van der Windt D.J., Campanile N., et al. Metabolic aspects of pig-to-monkey (Macaca fascicularis) islet transplantation: implications for translation into clinical practice. Diabetologia 2008, 51:120-129.
75. Pan Z., Sun C., Jie Y., Wang N., Wang L. WZS-pig is a potential donor alternative in corneal xenotransplantation. Xenotransplantation 2007, 14:603-611.
76. Oh J.Y., Kim M.K., Ko J.H., Lee H.J., Park C.G., Kim S.J., et al. Histological differences in full-thickness vs. lamellar corneal pig-to-rabbit xenotransplantation. Vet Ophthalmol 2009, 12:78-82.
77. Hara H, Koike N, Long C, Piluex J, Roh DS, Sundarraj N, et al. Initial in vitro investigation of the human immune response to corneal cells from genetically-engineered pigs. 2010. [Submitted for publication].
78. Badin R.A., Padoan A., Vadori M., Boldrin M., De Benedictis G.M., Fante F., et al. Porcine embryonic xenografts transgenic for CTLA4-Ig enable longterm recovery in Parkinsonian macaques. Am J Transplant 2010, 10(Suppl. 4):208. (Abstract LB01).
79. Zhu A. Introduction to porcine red cells;implications for xenotransplantation. Sem Hematol 2000, 37:143-149.
80. Cooper D.K.C., Hara H., Yazer M. Genetically-engineered pigs as a source for clinical red blood cell transfusion. Clin Lab Med 2010, 30:365-380.
81. Cooper D.K.C. Porcine red blood cells as a source of blood transfusion in humans. Xenotransplantation 2003, 10:384-385.
82. Long C., Hara H., Pawlikowski Z., Koike N., d'Arville T., Yeh P., et al. Genetically-engineered pig red blood cells for clinical transfusion:initial in vitro studies. Transfusion 2009, 49:2418-2429.
83. Onions D., Cooper D.K.C., Alexander T.J.L., Brown C., Claassen E., Foweraker J.E., et al. An assessment of the risk of xenozoonotic disease in pig-to-human xenotransplantation. Xenotransplantation 2000, 7:143-155.
84. Fishman J.A., Patience C. Xenotransplantation:infectious risk revisited. Am J Transplant 2004, 4:1383-1390.
85. Dieckhoff B., Karlas A., Hofmann A., Kues W.A., Petersen B., Pfeifer A., et al. Inhibition of porcine endogenous retroviruses (PERVs) in primary porcine cells by RNA interference using lentiviral vectors. Arch Virol 2007, 152:629-634.
86. Dieckhoff B., Petersen B., Kues W.A., Kurth R., Niemann H., Denner J. Knockdown of porcine endogenous retrovirus (PERV) expression by PERV-specific shRNA in transgenic pigs. Xenotransplantation 2008, 15:36-45.
87. Ramsoondar J., Vaught T., Ball S., Mendicino M., Monahan J., Jobst P., et al. Production of transgenic pigs that express porcine endogenous retrovirus small interfering RNAs. Xenotransplantation 2009, 16:164-180.
88. Tibell A., Lundgren T. Xenotransplantation-clinical activities and regulatory development. Acta Vet Scand 2004, 99(Suppl.):19-23.
89. Schuurman H.J. Regulatory aspects of pig-to-human islet transplantation. Xenotransplantation 2008, 15:116-120.
90. World Health Organization First WHO global consultation on regulatory requirements for xenotransplantation clinical trials, Changsha, China, 19-21 November 2008. Xenotransplantation 2009, 16:58-60. The Changsha Communiqué.
91. Sykes M., d'Apice A., Sandrin M. IXA ethics committee. position paper of the ethics committee of the international xenotransplantation association. Transplantation 2004, 78:1101-1107.
92. Daly K.A., Stewart-Akers A.M., Hara H., Ezzelarab M., Long C., Cordero K., et al. Effect of the αGal epitope on the response to small intestinal submucosa extracellular matrix in a nonhuman primate model. Tissue Eng Part A 2009, 15:3877-3888.